Middle East & Africa Needle-Free Injection Systems Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle-free Injectors, Projectile-based Needle-free Injectors, and Powder-Based Needle-free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)
The Middle East & Africa needle-free injection systems market is expected to grow from US$ 7.25 million in 2022 to US$ 17.89 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028.
Increasing Incidence of Communicable Diseases due to Needlestick Injuries Boost the Middle East & Africa Needle-Free Injection Systems Market
Needlestick injuries (NSIs) are one of the major concerns for most healthcare providers, and it is considered one of the most serious health and safety threats. The pooled prevalence of needlestick injuries among healthcare workers in 2020 was 32.4%. Further, according to the article published by the International Journal of Environment Research & Public Health 2022, the incidence of NSIs in Saudi Arabia is highest among physicians (36%), followed by nurses (34.8%), dentists (29.2%), and medical technologists (21.1%). Thus, above-mentioned factors are boosting the growth of the Middle East & Africa needle-free injection systems market.
Middle East & Africa Needle-Free Injection Systems market Overview
The Middle East & Africa needle-free injection system market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia holds the largest share of the Middle East & Africa needle-free injection systems market owing to several factors such as increasing strategic initiatives by market players for launching their products in the region, rising incidence of chronic diseases, and growing healthcare infrastructure along with the increasing need for vaccines in the region.
Saudi Arabia is one of the fastest-growing regions in the Middle East & Africa, whose growth is driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and autoimmune diseases. Rising awareness of health issues and growing adoption of needle-free injections for injectable drugs are the factors fueling the needle-free injection systems market growth. The burden of chronic diseases is significant in Saudi Arabia, which is expected to increase the demand for the Middle East & Africa needle-free injection systems market.
The World Health Organization has ranked Saudi Arabia as having the second-highest rate of diabetes in the Middle East and seventh-highest in the world. It is estimated that 7 million have diabetes and more than 3 million have pre-diabetes in Saudi Arabia. Over the last two decades, in Saudi, there has been a rise in the expenses of healthcare and treatment of diabetes by more than 500%. In diabetic patients, needle-free injectors can be used to inject insulin as a painless and easy-to-use treatment. Thus, the demand for needle-free injection systems is increasing, boosting the Middle East & Africa needle-free injection systems market growth.
Middle East & Africa Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Middle East & Africa Needle-Free Injection Systems Market SegmentationThe Middle East & Africa needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the Middle East & Africa needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.
Based on technology, the Middle East & Africa needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.
Based on type, the Middle East & Africa needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.
Based on durability, the Middle East & Africa needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.
Based on site of delivery, the Middle East & Africa needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.
Based on application, the Middle East & Africa needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.
Based on end user, the Middle East & Africa needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.
Based on country, the Middle East & Africa needle-free injection systems market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.
Aijex Pharma International Inc., Crossject, Ferring B.V., and Zealand Pharma A/S are the leading companies operating in the needle-free injection systems market in the Middle East & Africa.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Needle Free Injection Systems Market – By Product
1.3.2 Middle East & Africa Needle Free Injection Systems Market – By Technology
1.3.3 Middle East & Africa Needle Free Injection Systems Market – By Type
1.3.4 Middle East & Africa Needle Free Injection Systems Market – By Usability
1.3.5 Middle East & Africa Needle Free Injection Systems Market – By Site of Delivery
1.3.6 Middle East & Africa Needle Free Injection Systems Market – By Application
1.3.7 Middle East & Africa Needle Free Injection Systems Market – By End User
1.3.8 Middle East & Africa Needle Free Injection Systems Market – By Country
2. Middle East & Africa Needle Free Injection Systems Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Needle Free Injection Systems Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Needle Free Injection Systems Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
5.1.2 Advantages of Using Self-injection Devices
5.2 Market Restraints
5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
5.3 Market Opportunities
5.3.1 Rising Demand for Vaccines and Biosimilars
5.4 Future Trends
5.4.1 Surge in New Technologies for Needle Free Injection System
5.5 Impact Analysis
6. Needle Free Injection System Market – Middle East & Africa Analysis
6.1 Middle East & Africa Needle Free Injection System Marker Revenue Forecast and Analysis
7. Middle East & Africa Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Product
7.1 Overview
7.2 Middle East & Africa Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
7.3 Fillable Needle Free Injectors
7.3.1 Overview
7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
7.4 Prefilled Needle Free Injectors
7.4.1 Overview
7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Technology
8.1 Overview
8.2 Middle East & Africa Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
8.3 Jet-Based Needle-Free Injectors
8.3.1 Overview
8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Spring-Based Needle-Free Injectors
8.4.1 Overview
8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Microarray Patch Injectors
8.5.1 Overview
8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)
9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Type
9.1 Overview
9.2 Middle East & Africa Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
9.3 Liquid-Based Needle-Free Injectors
9.3.1 Overview
9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.4 Projectile-Based Needle-Free Injectors
9.4.1 Overview
9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.5 Powder-Based Needle-Free Injectors
9.5.1 Overview
9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
10. Middle East & Africa Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Usability
10.1 Overview
10.2 Middle East & Africa Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
10.3 Disposable
10.3.1 Overview
10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
10.4 Reusable
10.4.1 Overview
10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)
11. Middle East & Africa Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Site of Delivery
11.1 Overview
11.2 Middle East & Africa Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
11.3 Subcutaneous Injectors
11.3.1 Overview
11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.4 Intramuscular Injectors
11.4.1 Overview
11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.5 Intradermal Injectors
11.5.1 Overview
11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)
12. Middle East & Africa Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Application
12.1 Overview
12.2 Middle East & Africa Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
12.3 Vaccine Delivery
12.3.1 Overview
12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.4 Insulin Delivery
12.4.1 Overview
12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.5 Pain Management
12.5.1 Overview
12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
12.6 Oncology
12.6.1 Overview
12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.7 Dermatology
12.7.1 Overview
12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.8 Others
12.8.1 Overview
12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)
13. Middle East & Africa Needle Free Injection Systems Market Analysis– By End User
13.1 Overview
13.2 Middle East & Africa Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
13.3 Pharmaceutical and Biotechnology Companies
13.3.1 Overview
13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.4 Hospitals
13.4.1 Overview
13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.5 Research Laboratories
13.5.1 Overview
13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.6 Home Care Settings
13.6.1 Overview
13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.7 Other End User
13.7.1 Overview
13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
14. Middle East & Africa Needle Free Injection Systems Market Revenue and Forecasts to 2028 – Country Analysis
14.1 Overview
14.1.1 Middle East & Africa: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
14.1.1.1 Saudi Arabia: Needle Free Injection System Market– Revenue and Forecast to 2028 (USD Thousand)
14.1.1.1.1 Saudi Arabia: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.1.2 Saudi Arabia: Needle Free Injection System Market, by Product, 2019–2028 (USD Thousand)
14.1.1.1.3 Saudi Arabia: Needle Free Injection System Market, by Technology, 2019–2028 (USD Thousand)
14.1.1.1.4 Saudi Arabia: Needle Free Injection System Market, by Type, 2019–2028 (USD Thousand)
14.1.1.1.5 Saudi Arabia: Needle Free Injection System Market, by Usability, 2019–2028 (USD Thousand)
14.1.1.1.6 Saudi Arabia: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (USD Thousand)
14.1.1.1.7 Saudi Arabia: Needle Free Injection System Market, by Application, 2019–2028 (USD Thousand)
14.1.1.1.8 Saudi Arabia: Needle Free Injection System Market, by End User, 2019–2028 (USD Thousand)
14.1.1.2 South Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.2.1 South Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.2.2 South Africa: Needle Free Injection System Market, by Product, 2019–2028 (USD Thousand)
14.1.1.2.3 South Africa: Needle Free Injection System Market, by Technology, 2019–2028 (USD Thousand)
14.1.1.2.4 South Africa: Needle Free Injection System Market, by Type, 2019–2028 (USD Thousand)
14.1.1.2.5 South Africa: Needle Free Injection System Market, by Usability, 2019–2028 (USD Thousand)
14.1.1.2.6 South Africa: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (USD Thousand)
14.1.1.2.7 South Africa: Needle Free Injection System Market, by Application, 2019–2028 (USD Thousand)
14.1.1.2.8 South Africa: Needle Free Injection System Market, by End User, 2019–2028 (USD Thousand)
14.1.1.3 UAE: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.3.1 UAE: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.3.2 UAE: Needle Free Injection System Market, by Product, 2019–2028 (USD Thousand)
14.1.1.3.3 UAE: Needle Free Injection System Market, by Technology, 2019–2028 (USD Thousand)
14.1.1.3.4 UAE: Needle Free Injection System Market, by Type, 2019–2028 (USD Thousand)
14.1.1.3.5 UAE: Needle Free Injection System Market, by Usability, 2019–2028 (USD Thousand)
14.1.1.3.6 UAE: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (USD Thousand)
14.1.1.3.7 UAE: Needle Free Injection System Market, by Application, 2019–2028 (USD Thousand)
14.1.1.3.8 UAE: Needle Free Injection System Market, by End User, 2019–2028 (USD Thousand)
14.1.1.4 Rest of Middle East & Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.4.1 Rest of Middle East & Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
14.1.1.4.2 Rest of Middle East & Africa: Needle Free Injection System Market, by Product, 2019–2028 (USD Thousand)
14.1.1.4.3 Rest of Middle East & Africa: Needle Free Injection System Market, by Technology, 2019–2028 (USD Thousand)
14.1.1.4.4 Rest of Middle East & Africa: Needle Free Injection System Market, by Type, 2019–2028 (USD Thousand)
14.1.1.4.5 Rest of Middle East & Africa: Needle Free Injection System Market, by Usability, 2019–2028 (USD Thousand)
14.1.1.4.6 Rest of Middle East & Africa: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (USD Thousand)
14.1.1.4.7 Rest of Middle East & Africa: Needle Free Injection System Market, by Application, 2019–2028 (USD Thousand)
14.1.1.4.8 Rest of Middle East & Africa: Needle Free Injection System Market, by End User, 2019–2028 (USD Thousand)
15. Needle-Free Injection System Market–Industry Landscape
15.1 Overview
15.2 Growth Strategies Done by the Companies in the Market (%)
15.3 Organic Developments
15.3.1 Overview
15.4 Inorganic Developments
15.4.1 Overview
16. Company Profiles
16.1 Crossject
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Zealand Pharma A/S
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Medical International Technologies (MIT Canada) Inc.
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 NuGen Medical Devices
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Ferring B.V.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
17. Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (USD Thousand)
Table 2. Saudi Arabia Needle Free Injection System Market, by Technology– Revenue and Forecast to 2028 (USD Thousand)
Table 3. Saudi Arabia Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 4. Saudi Arabia Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Saudi Arabia Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (USD Thousand)
Table 6. Saudi Arabia Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (USD Thousand)
Table 7. Saudi Arabia Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (USD Thousand)
Table 8. South Africa Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (USD Thousand)
Table 9. South Africa Needle Free Injection System Market, by Technology– Revenue and Forecast to 2028 (USD Thousand)
Table 10. South Africa Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 11. South Africa Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (USD Thousand)
Table 12. South Africa Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (USD Thousand)
Table 13. South Africa Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (USD Thousand)
Table 14. South Africa Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (USD Thousand)
Table 15. UAE Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (USD Thousand)
Table 16. UAE Needle Free Injection System Market, by Technology– Revenue and Forecast to 2028 (USD Thousand)
Table 17. UAE Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 18. UAE Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (USD Thousand)
Table 19. UAE Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (USD Thousand)
Table 20. UAE Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (USD Thousand)
Table 21. UAE Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (USD Thousand)
Table 22. Rest of Middle East & Africa Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (USD Thousand)
Table 23. Rest of Middle East & Africa Needle Free Injection System Market, by Technology– Revenue and Forecast to 2028 (USD Thousand)
Table 24. Rest of Middle East & Africa Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 25. Rest of Middle East & Africa Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (USD Thousand)
Table 26. Rest of Middle East & Africa Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (USD Thousand)
Table 27. Rest of Middle East & Africa Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (USD Thousand)
Table 28. Rest of Middle East & Africa Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (USD Thousand)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Needle Free Injection Systems Market Segmentation
Figure 2. Middle East & Africa Needle Free Injection Systems Market, By Country
Figure 3. Middle East & Africa Needle Free Injection Systems Market Overview
Figure 4. Fillable Needle-Free Injectors Segment Held Largest Share of Product Segment in Middle East & Africa Needle Free Injection Systems Market
Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Middle East & Africa Needle Free Injection Systems Market Impact Analysis of Driver and Restraints
Figure 8. Middle East & Africa Needle Free Injection System Market – Revenue Forecast and Analysis – 2019–2028
Figure 9. Middle East & Africa Needle Free Injection Systems Market, by Product 2022 & 2028 (%)
Figure 10. Fillable Needle Free Injectors: Revenue and Forecasts to 2028 (US$ Thousand)
Figure 11. Prefilled Needle Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 12. Middle East & Africa Needle Free Injection Systems Market, by Technology 2022 & 2028 (%)
Figure 13. Jet-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 14. Spring-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 15. Microarray Patch Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 16. Others - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 17. Middle East & Africa Needle Free Injection Systems Market, by Type 2022 & 2028 (%)
Figure 18. Liquid-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 19. Projectile-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 20. Powder-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. Middle East & Africa Needle Free Injection Systems Market, by Usability 2022 & 2028 (%)
Figure 22. Disposable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 23. Reusable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 24. Middle East & Africa Needle Free Injection Systems Market, by Site of Delivery 2022 & 2028 (%)
Figure 25. Subcutaneous Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 26. Intramuscular Injector - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 27. Intradermal Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 28. Middle East & Africa Needle Free Injection Systems Market, by Application 2022 & 2028 (%)
Figure 29. Vaccine Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 30. Insulin Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 31. Pain Management - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 32. Oncology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 33. Dermatology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 34. Others - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 35. Middle East & Africa Needle Free Injection Systems Market, by End User 2022 & 2028 (%)
Figure 36. Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 37. Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 38. Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 39. Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 40. Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 41. Middle East & Africa: Needle Free Injection System Market, by Key Country – Revenue (2022) (USD Thousand)
Figure 42. Middle East & Africa: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
Figure 43. Saudi Arabia: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 44. South Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 45. UAE: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 46. Rest of Middle East & Africa: Needle Free Injection System Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 47. Growth Strategies Done by the Companies in the Market (%)
- Crossject
- Ferring B.V.
- Medical International Technologies (MIT Canada) Inc.
- NuGen Medical Devices
- Zealand Pharma A/S
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa needle-free injection systems market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution